"Bayer-ly" An Rx Company? Viadur Is Focus Of New Bayer Oncology Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer is setting up a new oncology division in West Haven, Conn. as the focus of its U.S. prescription drug business following a Sept. 13 licensing deal with Schering-Plough
You may also be interested in...
Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma
$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.
Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma
$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.
Bayer Spring Investor Conference March 16 Will Stress 2004 Financial Upturn
Restructuring is seen as a key factor in Bayer's improved performance. Its U.S. oncology business and ex-U.S. Levitra promotion are among likely topics for updates at the investor meeting.